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An evaluation of paediatric medicines reconciliation at hospital  
discharge into the community 
ABSTRACT  
 
Objective 
A UK national survey of primary care physicians has indicated that the 
medication information on hospital discharge summary was incomplete or inaccurate 
most of the time. Internationally, studies have shown that hospital pharmacist’s 
interventions reduce these discrepancies in the adult population. There have been 
no published studies on the incidence and severity of the discrepancies of the 
medication prescribed for children specifically at discharge to date.  The objectives of 
this study were to investigate the incidence, nature and potential clinical severity of 
medication discrepancies at the point of hospital discharge in a paediatric setting. 
Methods 
Five weeks prospective review of hospital discharge letters was carried out.  
Medication discrepancies between the initial doctor’s discharge letter and finalised 
drug chart were identified, pharmacist changes were recorded and their severity was 
assessed.  The setting of the review was at a London, UK paediatric hospital providing 
local secondary and specialist tertiary care.  The outcome measures were: incidence 
and the potential clinical severity of medication discrepancies identified by the hospital 
pharmacist at discharge. 
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Key findings 
142 patients (64 female and 78 males, age range 1 month – 18 years) were 
discharged on 501 medications.  The majority of patients were under the care of 
general surgery and general paediatric teams. One in three discharge letters 
contained at least one medication discrepancy and required pharmacist interventions 
to rectify prior to completion. Of these, 1 in 10 had the potential for patient harm if 
undetected.  
Conclusions 
Medicines reconciliation by pharmacist at discharge may be a good intervention 
in preventing medication discrepancies which have the potential to cause moderate 
harm in paediatric patients.   
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Manuscript   
BACKGROUND AIMS AND OBJECTIVES 
 
When patients are discharged from hospital, it is important that their 
medications and any changes that have occurred during their hospital stay are 
communicated accurately to their next healthcare provider, in order to reduce 
potentially harmful errors or medication related problems resulting in hospitalisation.[1]   
A UK government national survey, exploring organisational processes for 
patients discharged from hospital found that only 27% of the general practitioners 
(primary care physicians) reported that the discharge summaries were accurate or 
complete. Furthermore, 81% of practices reported that details of the prescribed 
medications were incomplete or inaccurate on discharge summaries “all” or “most” of 
the time.[2] 
  Another survey found that doctors themselves updated patient records 
following hospital discharge in 78% of their practices, with a small number of surgeries 
delegating the task to nurses and pharmacists and 17% to non-clinically trained staff. 
The report recommended that acute hospital trusts improve the discharge information 
about medications. The report also recommended guidance for general practices 
(primary care physician clinics) with regards to reconciling medications after patient 
discharge.[2] 
Medication issues across the interface of care between hospital discharge and 
primary care is not just a UK health systems based problem, as studies identifying 
drug-related problem have also been explored in other countries such as New 
Zealand[3] and USA[4]. 
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Most of the previous research has focused on adult medicines reconciliation 
and medication errors.[5,6] However, paediatric patients have an increased risk of 
medication errors specifically dosing errors due to the fact that there is a need for 
dosage calculations which are individually based on the patient’s weight, age, or body 
surface area and their condition.  Also many drugs are unlicensed leading to variances 
in formulation and potential changes in bioavailability.[7]  
A review of patient safety incidents in the UK involving medication errors in 
children found that interface issues may have been a contributing factor. One of the 
strategies of minimising medication errors in children was improved communication 
between healthcare professionals in secondary and primary care.  However there is 
little evidence that improved communication would reduce medication errors in 
children.[8]   
Furthermore, there is a lack of evidence on medication discrepancies in 
hospitalised children across the interfaces of care including the point of hospital 
discharge.[9,10]  In one study of medication discrepancies upon discharge in children, 
it was found that 15% of children were affected [11] 
Internationally there is evidence to show that medication discrepancies that 
occur across the interface of care can be reduced by hospital-based medicines 
reconciliation practice that involve pharmacist interventions, such as involvement in 
screening discharge communications and counselling patients at hospital 
discharge.[12]  Randomised controlled trials conducted in the USA[13], Canada[14], and 
non-RCT studies in the USA[15] and Sweden[16] have demonstrated that pharmacist 
involvement in the discharge process where they check discharge medication lists 
have led to a decrease in medication discrepancies at discharge.   Previous studies 
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and trials observing the benefits of medicines reconciliation at hospital discharge were 
conducted in adults or were not specific to a paediatric setting.[13,14,15,16] 
To date, there has been no specific evaluation of the accuracy of the 
medication prescribed for children specifically at discharge. This information would 
be essential before developing an intervention and conducting any studies or trials to 
provide the evidence for the benefit of having a pharmacist led medicines 
reconciliation service at discharge.  It is essential that this stage of discharge is 
accurate and clear to enable safe and effective transfer of care to the community. 
Many paediatric medicines reconciliation based studies in the past have mainly 
aimed to observe medication discrepancies that occur at hospital admission[17,18] with 
only one small Canadian study published as a conference abstract.  This study 
observed that medication discrepancies occurred at hospital discharge in a very 
small sample of charts reviewed retrospectively.[11] 
Aims and Objectives  
The main aims and objectives of this study were to investigate the incidence 
and nature of medication prescribing discrepancies at the point of hospital discharge 
in a paediatric setting and assess their potential impact of harm to the patient by 
evaluating their potential clinical severity. 
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METHODS 
 
A consecutive prospective review of electronically generated discharge 
medication orders for paediatric patients discharged at a London teaching hospital 
was conducted over a five week period based on resources available for the study 
(March to April 2011).   
Procedure of discharge medicines reconciliation 
All discharge medication letters that were written by a hospital physician were 
recorded and transcribed onto a data collection form.  This record represented the 
“initial discharge medication list”. Once the discharge letter was amended by a 
pharmacist after discharge medicines reconciliation (see procedure below), “the 
pharmacist approved medication list” was recorded in the final discharge letter for the 
patient to take home and send to the general practice. This information was then 
recorded onto a data collection form as the “pharmacist’s approved discharge 
medication list”. This list was considered the complete and accurate medication list. 
A discharge discrepancy was defined as a difference between the “initial 
discharge medication list” written by the physician when compared against the 
“pharmacist’s approved medication list”.  The discrepancy was any difference in 
information between the two lists: - Medication name, brand, dose, dosage form (e.g. 
modified release, strength of liquid, capsules, tablet), directions and duration.   
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The following procedure of medicines reconciliation was adopted by the study 
hospital and was carried out as routine clinical practice at the time of the study.  Up to 
two days prior to the discharge of the patient an initial medication discharge letter was 
written by a hospital physician.  This medication discharge letter was electronically 
generated, with the function of free text typing medications that were not on the 
dropdown list of medications existing on the system. Once this initial discharge 
medication letter was written, it was passed onto a pharmacist to screen.  The 
pharmacist would check the record based on the final drug chart and would query any 
discrepancies with the patient’s discharging doctor.  Once the discrepancies were 
verified with the doctor and resolved, the pharmacist would return the discharge letter 
to the discharging doctor to amend on the electronic system and a finalised discharge 
letter was reprinted and this would be the patient’s/caregiver’s copy and sent to the 
community general practice. In addition to the reconciliation, the pharmacist would 
check the medications dispensed by the hospital pharmacy department and also re-
label any patient own medications which required direction of use changes.  
 
 
 
 
 
 10 
 
Data collection 
 The information that was used during the medicines reconciliation process and 
recorded for the study were:  
1) The finalised drug chart 
2) Initial discharge letter written by the doctor using the electronic system 
3) The pharmacist’s amended version of the discharge letter 
4) The finalised and amended discharge letter going out to the patient 
5) Discrepancies between the initial discharge letter written by the doctor and the 
pharmacist’s amended version.  
Severity assessment of medication discrepancies 
 
The clinical significance of the discrepancies between the initial prescribed 
discharge medications and the pharmacist’s amendments were assessed using a 
validated severity rating tool.[19] Five healthcare professionals consisting of 1) a 
consultant paediatrician (JJ), 2) a consultant pharmacist in paediatrics (ST), 3) a lead 
pharmacist in medication safety (YJ), 4) a pharmacist/senior lecturer in pharmacy 
practice (MG), and 5) a research pharmacist (CH) were sent an excel spreadsheet of 
discrepancies and asked to score the potential severity of each discrepancy using a 
visual analogue scale.  The visual analogue scale was a 10 point scale ranging from 
0 which represented no harm to 10 which represented death.  The mean score was 
calculated for each discrepancy and a severity score was assigned using the following 
criteria: minor harm (scores below 3), moderate harm (scores between 3 and 7) and 
severe harm (score above 7).[19,20]  
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Analysis 
All data from the study, which included the patient’s age, condition, specialty, 
and medication record from the final drug chart to the final discharge letter dispatched 
to the patient, were recorded. Data were entered into Microsoft Excel and data entry 
was double checked by CH and EH for quality assurance purposes.  The cleansed 
data was then transferred to the software SPSS version 19 for statistical analysis, such 
as descriptive frequencies in percentages, distributions such as median, interquartile 
range, and including interrater reliability (Cronbach Alpha) for the severity assessment.   
 
Ethical consideration 
This study was deemed a service evaluation project by the local NHS hospital 
site Research & Development Department and therefore NHS ethics committee 
approval was not required.   Although NHS ethics was not required, this project was 
approved by the School of Pharmacy, University of London Ethics Committee in 2011. 
 
RESULTS 
 
Over the five week prospective data collection period, 142 patients (64 female 
and 78 males, age range 1 month – 18 years) were discharged on 501 medications.  
The patients came from a range of clinical specialties, with the majority of patients 
under the care of general surgery and general paediatric teams (n=109, 77%) with few 
patients under the care of respiratory teams (n=13, 9%), neurology teams (n=8, 6%) 
and other teams (n=12,8%).  Most of the drugs that were prescribed on the discharge 
letters were non-opioid analgesic medicines, non-steroidal anti-inflammatory drugs, as 
well as antibiotics. There were a wide range of other medications.  A breakdown of the 
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top 20 types of medications ordered on the discharge letter as per British National 
Formulary is given in Table 1.  
On comparing the initial discharge letter and pharmacist amendments, 99/501 
(20%) of medication orders were found to contain discrepancies and 47/142 (33%) of 
patients had at least one discrepancy with a median of 1 discrepancy per patient 
(range 1 – 12 discrepancies per patient, inter-quartile range 1 – 3).   
The discrepancies were clinically assessed for the potential severity of harm it 
would pose to the patient, if it had not been identified upon discharge.  The interrater 
reliability of the scorings between the 5 judges was calculated to be a Cronbach alpha 
value of 0.872, which reflected a high level of reliability.  Of the 99 discrepancies, 78% 
(77/99) had scores of <3 representing potential of minor harm, and 22% (22/99) of 
discrepancies (affecting 15 patients) had scores of 3-7 representing potential for 
moderate harm; none of the discrepancies were considered to have severe harm 
potential.  The median severity score was 1.48 (IQR = 0.71 – 2.89, minimum 0.18, 
maximum 6.38). Examples of potentially minor and moderately severe discrepancies 
are shown on Table 2.  Medication discrepancy types with examples are presented in 
Table 3.   
DISCUSSION 
 
The results from this first UK prospective study of the accuracy of discharge 
letters in paediatric patients showed that a third of the discharge letters written by the 
hospital physicians contained discrepancies when compared to the pharmacist’s 
checked and amended final version. The discrepancies were identified and rectified 
by hospital pharmacists who screened the discharge letters for accuracy and 
reconciled the medication list as part of their routine clinical work.    
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Our study adds to and strengthens the evidence base of medicines 
reconciliation at discharge for children.  The only similar study identified from existing 
literature, was a retrospective review of discharge letters at a paediatric hospital in 
Canada which indicated that 12 out of 28 (42%) of patients had at least one discharge 
discrepancy between the discharge medication ordered and a “best practice 
medication discharge plan”. This Canadian study had a higher proportion of 
discrepancies than our study, despite having a small sample size which means that 
the result could possibly be due to random fluctuation.[11] In comparison to adult 
studies, our discrepancy incidence of 33% differed to the incidence found in USA and 
Canadian studies, which found a higher rate of 59.6% and 41.3% respectively.[21,15] 
These figures may not be comparable as different definitions had been used to define 
a discrepancy in each study.  There were a number of limitations to the study. The 
study was conducted in one paediatric hospital in the UK and the duration of the study 
was short. Only the discharge letters that were reviewed within pharmacy operational 
hours were included in the study. Pharmacist amendments of the discharge letter were 
recorded on a data collection form, however the individual discussions between the 
doctor and pharmacist making the change were not recorded. Furthermore, some 
medication discrepancies might not have been identified via the pharmacist’s check.  
Despite these limitations, the study suggests that there are problems and issues of a 
moderately severe nature when discharge prescriptions are written to transfer children 
from one setting to another. 
 
The current study showed that in terms of potential patient safety risk in the 
absence of a pharmacist’s check, 22% of unintended discrepancies at discharge had 
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the potential to cause moderate harm if not resolved.  These discrepancies were 
identified by a paediatric ward pharmacist as differing from the discharging drug chart 
and were verified as unintended – e.g. it was not intentional by the physician. This 
finding strikes similarities when compared to other studies.  In a Canadian adult study 
by Wong et al. there were 29.5% of unintended discrepancies at discharge that had 
the potential to cause possible or probable patient discomfort or clinical 
deterioration.[21] However, the clinical severity assessment methodology in both 
studies was different in our study, we used a visual analogue scale with five assessors, 
and the study by Wong et al used a three point scale rating by three assessors. The 
study outcomes of the current study had a lower incidence of patients who had 
discrepancies when compared with an Irish study of cardiology adult patients by 
Grimes et al, which found a higher incidence of 65% of patients with at least one 
unintended discrepancy.[22] However the discrepancies from this adult study of 
cardiology patients also did not have potentially serious discrepancies when assessed 
for severity of clinical outcome and only had 47% of discrepancies being minor and 
53% being moderate. The study by Grimes et al. used the same method of severity 
assessment. One US adult study that explored discharge discrepancies reported 
higher incidences of discrepancies when compared to the current study, with the 
incidence reported at 45%, however the study cohort were limited to patients being 
prescribed dysphagia medications on discharge letters.[23] 
 
Our study suggests that pharmacists screening and review of discharge 
medication letters prevents 1 in 5 potentially harmful discrepancies from leaving the 
hospital.  This study highlights and provides evidence for pharmacists to conduct 
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medicines reconciliation at discharge in children. Reconciliation at discharge is shown 
to improve the accuracy of discharge letter by directly reducing medication errors.  This 
finding provides supporting evidence and justifies the role and routine clinical practice 
of pharmacists carrying out medicines reconciliation at discharge to keep patients 
safe.   
 
Further work is required to assess the generalisability of the findings, by 
repeating the study and measure the impact of pharmacist led discharge medicines 
reconciliation in children at other sites, and to explore the causes of the 
discrepancies identified.  An intervention can then be modelled and developed once 
the causes of discrepancies are better understood.  As medicines reconciliation has 
been adopted across paediatric hospitals and other hospitals across England that 
have paediatric wards, conducting a Randomised Controlled Trial would not be 
feasible[24]. As the economic evidence of pharmacist led medicines reconciliation at 
hospital admission was found to be a cost effective intervention to prevent medication 
errors,[25] a future study of the cost effectiveness of medicines reconciliation at 
discharge is required.  There is also a need to evaluate the accuracy of discharge 
letters written out of hours where pharmacist cover is reduced.    
CONCLUSION 
This study highlights that one in three discharge letters written by discharging 
physicians contained at least one medication discrepancy, all of which were resolved 
by the pharmacist. This finding supports the role of pharmacist led medicines 
reconciliation as an intervention to prevent these discrepancies from occurring.  
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Further work is required to find out if medication discrepancies occur post hospital 
discharge. 
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Table 1 List of the top 20 medications ordered on the discharge letter per British 
National Formulary classification 
BNF Chapter - Drug categories Number of Drugs 
(Frequency) 
4.7.1 Non-opioid analgesic 95 
10.1.1 Non-steroidal anti-inflammatory drugs 67 
5.1.1 Penicillins 51 
4.8.1 Control of the epilepsies 21 
1.6.4 Osmotic laxatives 20 
4.7.2 Opioid analgesic 17 
1.3.1 H2-receptor antagonists 14 
3.1.1.1 Selective beta2 agonists 10 
3.2 Corticosteroids 10 
9.1.1.1 Oral iron 10 
1.6.2 Stimulant laxatives 9 
1.3.5 Proton pump inhibitors 8 
1.5.2 Corticosteroids 8 
4.6 Drugs used in nausea and vertigo 8 
6.1.1 Insulins 7 
3.4.1 Antihistamines 6 
4.1.1 Hypnotics 6 
10.2.2 Skeletal muscle relaxants 5 
13.2.1.1 Emollient bath and shower preparations 5 
4.8.2 Drugs used in status epilepticus 5 
 
Table 2: Example of a minor and moderate discrepancy 
Patient 
ID 
Age 
(year, 
months) 
Weight 
(kg)  
Description of discrepancy Mean 
score 
Severity 
22 14 years 28.8 Initial TTA does not state that 
ranitidine 90mg twice a day should 
only be used "whilst on ibuprofen 
only" 
 
1.71 Minor 
138 3 years 5 
months 
13.2 In the initial TTA the patient was 
prescribed Sodium Valproate 200mg 
suspension to be taken twice daily. 
This was changed to three times daily 
which was the patient’s current dose 
in the final TTA. 
 
4.36 Moderate 
 
TTA = To Take Away.  Abbreviation of discharge letter used in clinical practice. 
EPR = Electronic Prescribing Record 
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Table 3 - Types of discharge discrepancies 
Type of discrepancy at 
discharge 
Example of discrepancy Frequency 
(percentage out of 
142 discrepancies 
in total) 
Directions of use, including 
formulation, route and 
duration.   
Direction example 
11 year old patient. 39.8kg.   
The initial discharge letter for TTA stated that 
Dermol  was initially directed to be used every 
morning, but changed to be used as a soap 
substitute on the final TTA. 
 
Direction and route 
7 years 7 months old patient. 14.4kg 
Baclofen 5mg liquid three times daily via oral 
route on initial TTA, changed to liquid - take 5mg 
twice daily via PEG on final TTA. 
 
Formulation 
6 years 7 months. 23 kg. 
On initial TTA Paracetamol tablets were 
prescribed, switch to liquid on final TTA. Dose 
was 250mg four times a day.   
 
Duration 
11 months 2 weeks old patient. 11kg. 
On the initial TTA Flucloxacillin 62.5mg four 
times a day is to be taken for six days and 
stopped on 15/3/11 , stop date changed by the 
pharmacist to 21/3/11 
34 (24%) 
Incorrect form 12 year old patient. 29.7kg.   
On initial TTA Insulin Levemir 6 units 
subcutaneous injection each night was 
prescribed as Flexpen, changed to cartridge by 
pharmacist on final TTA. 
28 (20%) 
Omitted medication 16 year old patient. 73.8kg.  
Biscacodyl 4mg rectal solution - take every other 
day - was omitted from initial discharge letter for 
the TTA, added on by pharmacist. 
15 (11%) 
No longer required drugs 2 years 1 month. 9.76kg. 
Topiramate 30mg tablets - 30mg twice a day 
taken off TTA by pharmacist, deemed 
unnecessary. 
14 (10%) 
Duplicated medication Patient 5 years 9 months.  20kg.  
Gabapentin 100mg to be taken three times daily 
duplicated on discharge letter for TTA. 
 9 (6%) 
Incorrect dose Patient 11 years. 39.8kg. 
Clonazepam 250mg suspension - take 250mg 
each morning on initial TTA changed to 200mg 
suspension – take 200mg each morning 
8 (6%) 
Incorrect medicine (including 
spelling errors) 
4 months 1 week. 2.8kg. 
Incorrect spelling of medicine- Syntron 1ml oral 
each morning written on TTA instead of Sytron 
3 (2%) 
TTA = To Take Away.  Abbreviation of discharge letter used in clinical practice. 
PEG = Percutaneous endoscopic gastronomy tube 
 
